TELCON RF PHARMACEUTICAL. Inc.

KOSDAQ 200230.KQ

TELCON RF PHARMACEUTICAL. Inc. Free Cash Flow for the year ending December 31, 2023: USD -2.33 M

TELCON RF PHARMACEUTICAL. Inc. Free Cash Flow is USD -2.33 M for the year ending December 31, 2023, a -0.73% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

TELCON RF PHARMACEUTICAL. Inc. Free Cash Flow for the year ending December 31, 2022 was USD -2.31 M, a 55.24% change year over year.
TELCON RF PHARMACEUTICAL. Inc. Free Cash Flow for the year ending December 31, 2021 was USD -5.17 M, a -210.19% change year over year.
TELCON RF PHARMACEUTICAL. Inc. Free Cash Flow for the year ending December 31, 2020 was USD -1.67 M, a -149.12% change year over year.
TELCON RF PHARMACEUTICAL. Inc. Free Cash Flow for the year ending December 31, 2019 was USD 3.39 M, a 121.79% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

KOSDAQ: 200230.KQ

TELCON RF PHARMACEUTICAL. Inc.

CEO	Jin-Hun Lim
IPO Date	Nov. 24, 2014
Location	South Korea
Headquarters	54, Gongse-ro
Employees	125
Sector	Communication Services
Industries Telecommunications & Networking

Description

TELCON RF PHARMACEUTICAL. Inc. develops, produces, and sells RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is based in Yongin-si, South Korea.

Key trends

Past 5 years